Mehran Yazdanian

Lipophilicity in Drug Development: Too Much or Not Enough?

Christel A. S. Bergström, Mehran Yazdanian, M. Yazdanian, 2016, The AAPS Journal.

Commentary: Why Pharmaceutical Scientists in Early Drug Discovery Are Critical for Influencing the Design and Selection of Optimal Drug Candidates

John Morrison, Mehran Yazdanian, Margaret S. Landis, 2017, AAPS PharmSciTech.

The “High Solubility” Definition of the Current FDA Guidance on Biopharmaceutical Classification System May Be Too Strict for Acidic Drugs

Mehran Yazdanian, M. Yazdanian, A. Hawi, 2004, Pharmaceutical Research.

Mechanisms of Transport and Structure-Permeability Relationship of Sulfasalazine and Its Analogs in Caco-2 Cell Monolayers

Mehran Yazdanian, J. Proudfoot, M. Yazdanian, 2000, Pharmaceutical Research.